Column Group IV GP, LP - 10%+ Owner at Eikon Therapeutics, Inc.

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
EIKN on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Column Group IV GP, LP in Eikon Therapeutics, Inc.

Buys

Open market
Shares
+89,200
Avg price
$11.56
Total value
+$1,031,045

Sells

Open market
Shares
Avg price
Total value

Net

Past year
Shares
+89,200
Share %
100%
Total value
+$1,031,045

Reported holdings for Column Group IV GP, LP in Eikon Therapeutics, Inc.

Form 4 holding 10%+ Owner

Eikon Therapeutics, Inc.

Security class
Series A-1 Preferred Stock
Shares / value
0
Estimated value
Report date
06 Feb 2026
Price
Ownership
By The Column Group IV-A, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Eikon Therapeutics, Inc.

Security class
Series A-1 Preferred Stock
Shares / value
0
Estimated value
Report date
06 Feb 2026
Price
Ownership
By The Column Group IV, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Eikon Therapeutics, Inc.

Security class
Series A Preferred Stock
Shares / value
0
Estimated value
Report date
06 Feb 2026
Price
Ownership
By The Column Group IV-A, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Eikon Therapeutics, Inc.

Security class
Series A Preferred Stock
Shares / value
0
Estimated value
Report date
06 Feb 2026
Price
Ownership
By The Column Group IV, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Eikon Therapeutics, Inc.

Security class
Series C-1 Preferred Stock
Shares / value
0
Estimated value
Report date
06 Feb 2026
Price
Ownership
By The Column Group IV-A, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Eikon Therapeutics, Inc.

Security class
Series C-1 Preferred Stock
Shares / value
0
Estimated value
Report date
06 Feb 2026
Price
Ownership
By The Column Group IV, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Eikon Therapeutics, Inc.

Security class
Series D Preferred Stock
Shares / value
0
Estimated value
Report date
06 Feb 2026
Price
Ownership
By The Column Group Opportunity III, LP
Underlying class
Common Stock
Underlying amount

Transaction history for Column Group IV GP, LP in Eikon Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .